The U.S. Anti-Doping Agency (USADA) applauds the United States Attorney’s Office for the District of Massachusetts following the recent sentencing of a Massachusetts couple who were convicted of conspiring to illegally introduce misbranded drugs into interstate commerce.
Similar to the many cases prosecuted under the Rodchenkov Anti-Doping Act (RADA), this conviction is yet another example of how the U.S. is working to expose the truth and hold bad actors accountable in order to protect public health and clean sport.
“Today’s sentencing sends a clear message to anyone trying to camouflage illegal drug sales: You cannot disguise dangerous, illegal drugs as ‘research chemicals’ and expect to avoid accountability,” said USADA CEO Travis T. Tygart. “USADA is very grateful to the Department of Justice, the U.S. Attorney’s Office for the District of Massachusetts, and the FDA’s Office of Criminal Investigations for their commitment to protecting athletes and the public from those who put profit ahead of safety, fairness, and the law.”
Following a thorough investigation, it was established that the defendants falsely labeled products as “For Research Use Only” and “Not for Human Consumption” while knowing the products were being used as performance-enhancing drugs. The defendants’ scheme involved receiving hundreds of shipments from China, repackaging the drugs in a home laboratory, and distributing them to customers across the United States, generating more than $2.5 million in revenue and approximately $610,000 in profit.
USADA Chief Science Officer Dr. Matthew Fedoruk provided essential scientific evidence in the case through a detailed expert disclosure and was prepared to testify at trial before the defendants pleaded guilty. His analysis helped explain how the products were misrepresented, how they were prepared for human use, and why the defendants’ conduct posed serious risks to health and sport integrity.
“This case is another reminder that the grey market is not a harmless shortcut — it is often a direct pipeline for unsafe and illegal drugs,” said Fedoruk. “Scientific expertise is critical in these cases because investigators, prosecutors, and courts need to understand what these products are, how they’re marketed, and the real risks they create for athletes and the public.”
USADA will continue working prosecutors, law enforcement, and other partners in the U.S. and beyond to identify, investigate, and disrupt illegal schemes that threaten athletes, consumers, and the integrity of sport.
For more information or media inquiries, email Media@USADA.org.
